全文获取类型
收费全文 | 3007篇 |
免费 | 168篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 108篇 |
妇产科学 | 37篇 |
基础医学 | 480篇 |
口腔科学 | 56篇 |
临床医学 | 243篇 |
内科学 | 543篇 |
皮肤病学 | 52篇 |
神经病学 | 290篇 |
特种医学 | 505篇 |
外科学 | 248篇 |
综合类 | 45篇 |
预防医学 | 158篇 |
眼科学 | 18篇 |
药学 | 248篇 |
1篇 | |
中国医学 | 20篇 |
肿瘤学 | 98篇 |
出版年
2023年 | 20篇 |
2022年 | 26篇 |
2021年 | 36篇 |
2020年 | 19篇 |
2019年 | 28篇 |
2018年 | 48篇 |
2017年 | 37篇 |
2016年 | 44篇 |
2015年 | 40篇 |
2014年 | 72篇 |
2013年 | 88篇 |
2012年 | 118篇 |
2011年 | 100篇 |
2010年 | 95篇 |
2009年 | 107篇 |
2008年 | 92篇 |
2007年 | 95篇 |
2006年 | 105篇 |
2005年 | 124篇 |
2004年 | 103篇 |
2003年 | 86篇 |
2002年 | 69篇 |
2001年 | 97篇 |
2000年 | 77篇 |
1999年 | 85篇 |
1998年 | 106篇 |
1997年 | 103篇 |
1996年 | 102篇 |
1995年 | 79篇 |
1994年 | 56篇 |
1993年 | 63篇 |
1992年 | 45篇 |
1991年 | 40篇 |
1990年 | 58篇 |
1989年 | 78篇 |
1988年 | 62篇 |
1987年 | 63篇 |
1986年 | 70篇 |
1985年 | 79篇 |
1984年 | 42篇 |
1983年 | 40篇 |
1982年 | 34篇 |
1981年 | 39篇 |
1980年 | 47篇 |
1979年 | 15篇 |
1978年 | 24篇 |
1977年 | 31篇 |
1976年 | 22篇 |
1975年 | 22篇 |
1970年 | 4篇 |
排序方式: 共有3180条查询结果,搜索用时 0 毫秒
81.
82.
Boris Klempa Tatjana Avsic-Zupanc Jan Clement Tamara K. Dzagurova Heikki Henttonen Paul Heyman Ferenc Jakab Detlev H. Kruger Piet Maes Anna Papa Evgeniy A. Tkachenko Rainer G. Ulrich Olli Vapalahti Antti Vaheri 《Archives of virology》2013,158(3):521-529
Dobrava-Belgrade virus (DOBV) is a human pathogen that has evolved in, and is hosted by, mice of several species of the genus Apodemus. We propose a subdivision of the species Dobrava-Belgrade virus into four related genotypes – Dobrava, Kurkino, Saaremaa, and Sochi – that show characteristic differences in their phylogeny, specific host reservoirs, geographical distribution, and pathogenicity for humans. 相似文献
83.
Arpita Kulshrestha Vasundhra Bhandari Rupkatha Mukhopadhyay V. Ramesh Shyam Sundar Louis Maes Jean Claude Dujardin Syamal Roy Poonam Salotra 《Parasitology research》2013,112(2):825-828
Simple, cost-effective approach for routine surveillance of parasite susceptibility to antileishmanial drug miltefosine (MIL) is highly desirable for controlling emergence of drug resistance in visceral leishmaniasis (VL). We validated a simple resazurin-based fluorimetric assay using promastigotes to track natural MIL tolerance in Leishmania donovani parasites from VL cases (n?=?17) against standard amastigote assay, in two different labs in India. The inter-stage MIL susceptibility correlated strongly (r?=?0.70, p?=?0.0018) using J774.A.1 macrophage cell line-based amastigote assay and fluorescence-based resazurin assay for promastigotes. Investigation of inter-stage MIL susceptibility for the same set of clinical isolates in another lab also showed a strong correlation (r?=?0.72, p?=?0.0012) using mouse peritoneal macrophages for amastigote assay and resazurin-based alamar blue assay for promastigotes. Additionally, parasites from post-kala-azar dermal leishmaniasis (PKDL) lesions (n?=?7, r?=?0.78, p?=?0.046) and MIL-induced parasites (r?=?0.92, p?=?0.0001; n?=?3) also exhibited a strongly correlated inter-stage miltefosine susceptibility. Thus, our results support the utility of resazurin assay as a simplified biological tool for MIL susceptibility monitoring in clinical isolates from MIL-treated VL/PKDL patients. 相似文献
84.
85.
An alternative extrinsic pathway of human blood coagulation 总被引:7,自引:0,他引:7
To study the interrelationships of the major human coagulation pathways, factor X activation in normal and various deficient human plasmas was evaluated when clotting was triggered by dilute rabbit or human thromboplastin. Various dilutions of thromboplastin were added to plasma samples containing 3H-labeled factor X, and the time course of factor X activation was determined. At a 1/250 dilution of rabbit brain thromboplastin the rate of factor X activation in factor VIII or factor IX deficient plasma was only 10% of the activation rate seen for normal or factor XI deficient plasma. Reconstitution of the deficient plasmas with factors VIII or IX, respectively, restored normal factor X activation. Similar results were obtained when various dilutions of human thromboplastin replaced the rabbit thromboplastin. From these experiments, it is inferred that normal activation of factor X in plasma due to dilute thromboplastin requires factors VII, IX and VIII. An alternative extrinsic pathway that involves factors VII, IX, and VIII may be a major physiologic extrinsic pathway, and this pathway may help to explain the clinical observations of bleeding diatheses in patients deficient in factors IX or VIII. 相似文献
86.
87.
Elly Montrieux Wilmer H. Perera Marley García Louis Maes Paul Cos Lianet Monzote 《Parasitology research》2014,113(8):2925-2932
The search for new therapeutic agents from natural sources has been a constant for the treatment of diseases such as leishmaniasis. Herein, in vitro and in vivo pharmacological activities of pure major phenolic constituents (caffeic acid, chlorogenic acid, ferulic acid, quercetin, and rosmarinic acid) from Pluchea carolinensis against Leishmania amazonensis are presented. Pure compounds showed inhibitory activity against promastigotes (IC50?=?0.2–0.9 μg/mL) and intracellular amastigotes (IC50?=?1.3–2.9 μg/mL). Four of them were selected after testing against macrophages of BALB/c mice: caffeic acid, ferulic acid, quercetin, and rosmarinic acid, with selective indices of 11, 17, 10, and 20, respectively. Ferulic acid, rosmarinic acid, and caffeic acid controlled lesion size development and parasite burden in footpads from BALB/c experimentally infected mice, after five injections of compounds by intralesional route at 30 mg/kg every 4 days. Pure compounds from P. carolinensis demonstrated antileishmanial properties. 相似文献
88.
S. Hendrickx G. Boulet A. Mondelaers J. C. Dujardin S. Rijal L. Lachaud P. Cos P. Delputte L. Maes 《Parasitology research》2014,113(5):1875-1881
Although widespread resistance of Leishmania donovani and L. infantum against miltefosine (MIL) and paromomycin (PMM) has not yet been demonstrated, both run the risk of resistance selection. Unraveling the dynamics and mechanisms of resistance development is key to preserve drug efficacy in the field. In this study, resistance against PMM and MIL was experimentally selected in vitro in intracellular amastigotes of several strains of both species with different antimony susceptibility background. To monitor amastigote susceptibility, microscopic determination of IC50-values and promastigote back-transformation assays were performed. Both techniques were also used to evaluate the susceptibility of field isolates from MIL-relapse patients. PMM-resistance could readily be selected in all species/strains, although promastigotes remained fully PMM-susceptible. Successful MIL-resistance selection was demonstrated only by promastigote back-transformation at increasing MIL-concentrations upon successive selection cycles. Important to note is that amastigotes with the MIL-resistant phenotype could not be visualized after Giemsa staining; hence, MIL-IC50-values showed no shift. The same phenomenon was observed in a set of recent clinical isolates from MIL-relapse patients. This study clearly endorses the need to use intracellular amastigotes for PMM- and MIL-susceptibility testing. When monitoring MIL-resistance, promastigote back-transformation should be used instead of the standard Giemsa staining. In-depth exploration of the mechanistic background of this finding is warranted. 相似文献
89.
90.
M. Martín-Subero L. Berk S. Dodd V. Kamalesh M. Maes J. Kulkarni A. De Castella P.B. Fitzgerald M. Berk 《Comprehensive psychiatry》2014